PLATELET-DERIVED GROWTH-FACTOR LEVELS IN WOUNDS OF DIABETIC RATS

被引:83
|
作者
DOXEY, DL [1 ]
NG, MC [1 ]
DILL, RE [1 ]
IACOPINO, AM [1 ]
机构
[1] BAYLOR COLL DENT,DEPT BIOMED SCI,DALLAS,TX 75266
关键词
PLATELET-DERIVED GROWTH FACTOR; DIABETES; RADIOIMMUNOASSAY; IMMUNOHISTOCHEMISTRY; STREPTOZOTOCIN;
D O I
10.1016/0024-3205(95)02056-O
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Delayed wound healing is a troublesome complication of Diabetes. Results from recent investigations concerning the potential cellular and molecular mechanisms responsible for diabetic wound healing deficiency are preliminary in nature. Some studies have demonstrated that direct application of certain growth factors/cytokines can facilitate wound healing in diabetic models. It is possible that refractory diabetic wounds are the result of deficiencies in growth factors/cytokines important for the normal wound healing process. Platelet-Derived Growth Factor (PDGF) levels were examined by radioimmunoassay in wound tissue of normal and diabetic rats (streptozotocin-induced diabetes). Immunohistochemical analysis was utilized to localize and characterize PDGF immunopositive cells at the wound site of normal and diabetic animals. At the wound site, normal animals demonstrated significantly elevated PDGF levels compared to diabetic animals at 5 days post-wounding (no differences were observed in the spleen or contralateral control tissue). There appeared to be a visible increase in PDGF immunopositive cells at the wound site in both experimental and control groups. By day 10 post-wounding, PDGF levels at the wound site in normal animals were reduced becoming similar to PDGF levels in diabetic animals. This corresponded to an apparent reduction of PDGF immunopositive cells in both groups (similar to baseline levels). PDGF levels in both groups remained stable until day 20 post-wounding when a significant elevation of wound site PDGF levels occurred in the diabetic group. The findings suggest that absence of an initial increase in PDGF may play an important role in poor wound healing observed in diabetic animals. The reduction in PDGF may be related to decreased cellular PDGF production rather than a lack of PDGF-producing cells. Perhaps the diabetic state inhibits cellular PDGF gene expression signaled by wounding or interferes with normal PDGF expression at the wound site.
引用
收藏
页码:1111 / 1123
页数:13
相关论文
共 50 条
  • [21] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    RAINES, EW
    ROSS, R
    METHODS IN ENZYMOLOGY, 1985, 109 : 749 - 773
  • [22] PLATELET-DERIVED GROWTH-FACTOR IN EXPERIMENTAL GLOMERULONEPHRITIS
    ZHANG, G
    ELNAHAS, AM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (06) : 787 - 795
  • [23] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    MACIAG, T
    TRENDS IN BIOCHEMICAL SCIENCES, 1982, 7 (08) : 270 - 270
  • [24] A RADIORECEPTOR ASSAY FOR PLATELET-DERIVED GROWTH-FACTOR
    SINGH, JP
    METHODS IN ENZYMOLOGY, 1987, 147 : 13 - 22
  • [25] SIMILARITIES BETWEEN FIBROBLAST-DERIVED GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR
    DICKER, P
    POHJANPELTO, P
    PETTICAN, P
    ROZENGURT, E
    EXPERIMENTAL CELL RESEARCH, 1981, 135 (01) : 221 - 227
  • [26] PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR
    HELDIN, CH
    JOHNSSON, A
    EK, B
    WENNERGREN, S
    RONNSTRAND, L
    HAMMACHER, A
    FAULDERS, B
    WASTESON, A
    WESTERMARK, B
    METHODS IN ENZYMOLOGY, 1987, 147 : 3 - 13
  • [27] PLATELET-DERIVED GROWTH-FACTOR - PURIFICATION AND CHARACTERIZATION
    ANTONIADES, HN
    PANTAZIS, P
    METHODS IN ENZYMOLOGY, 1989, 169 : 210 - 224
  • [28] PRELIMINARY CHARACTERIZATION OF PLATELET-DERIVED GROWTH-FACTOR
    CHESTERMAN, CN
    DIGGLE, T
    DOYLE, DJ
    CULLIVER, H
    MORGAN, FJ
    PENINGTON, DG
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1979, 9 (05): : 604 - 605
  • [29] PLATELETS, PLATELET-DERIVED GROWTH-FACTOR AND ARTERIOSCLEROSIS
    BAUMGARTNER, HR
    HOSANG, M
    EXPERIENTIA, 1988, 44 (02): : 109 - 112
  • [30] PLATELET-DERIVED GROWTH-FACTOR AND MALIGNANT TRANSFORMATION
    ANTONIADES, HN
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (18) : 2823 - 2828